在晚期心力衰竭患者中,CardioMEMS和levosimendan之间的有利联盟
Valeria Visco1, Cristina Esposito2, Antonella Rispoli1
1Department of Medicine, Surgery and Dentistry, University of Salerno, Via Salvador Allende, 84081, Baronissi, Salerno, Italy.
ESC heart failure
|May 18, 2024
概括
使用 CardioMEMS 的连续远程监测显著减少了 50% 的心力衰竭住院治疗,并改善了患者的生活质量. 这一策略还导致了医疗保健成本的大幅节省,并减少了炎症标志物.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 健康 结果 研究 研究 结果
背景情况:
- 心力衰竭 (HF) 的管理仍然具有挑战性,需要创新策略来改善患者的治疗结果,并减少医疗保健负担.
- 连续远程监控为优化高频患者护理和资源利用提供了潜在的解决方案.
研究的目的:
- 评估 CardioMEMS 系统对心力衰竭患者医疗保健结果,成本和患者生活质量的现实影响.
- 评估连续远程监控在控制高压和减少住院治疗方面的有效性.
主要方法:
- 一项前性研究涉及七名心力衰竭患者,这些患者植入了 CardioMEMS 系统,用于日常远程监测.
- 收集临床,药理学,生化和心声回声数据,以及住院,急诊室访问和费用.
- 使用EQ-5D. 分析介质素-6 (IL-6) 水平和患者报告的生活质量.
主要成果:
- 在CardioMEMS植入后,总住院病例减少了50%,住院日数减少了68.7%.
- 显著改善患者的生活质量 (EQ-5D) 和心声学参数 (肺动脉压力,E/E').
- 统计学上显著降低高白素-6水平,并大幅节省成本 (每名患者平均净节省1580欧元).
结论:
- 卡迪奥MEMS系统为心力衰竭患者提供了积极的管理策略.
- 这种创新方法有效地防止了意外入院,优化了医疗保健资源的分配,降低了成本.
- 使用 CardioMEMS 的连续远程监测可以改善临床结果,提高患者的生活质量,并带来经济效益.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K